医学
食品药品监督管理局
遗产管理(遗嘱认证法)
婴儿配方奶粉
保健食品
药品管理局
替代医学
药品
环境卫生
食品科学
儿科
药理学
法学
政治学
化学
病理
作者
Sharon M. Donovan,Steven A. Abrams,Meghan B. Azad,Mandy B. Belfort,Lars Bode,Susan E. Carlson,David C. Dallas,Kasper Hettinga,Kirsi M. Järvinen,Jaehwan Kim,Carlito B. Lebrilla,Michelle K. McGuire,David A. Sela,Josef Neu
标识
DOI:10.1016/j.jpeds.2022.11.027
摘要
The US government and many professional societies recommend that human milk be the sole source of nutrition for infants up to 6 months-of-age.1,2 However, only about 25% of infants in the US meet this goal signaling an urgent need for improved multi-level support for breastfeeding among societies, communities, and families.2 In addition, when breastfeeding is not possible, access to a safe and effective source of nutrition—provided by infant formula (IF) is critical. The search for bioactive ingredients found in human milk (HM) that could be added to formula has been intense among academic institutions, governmental research institutes, and industry.
科研通智能强力驱动
Strongly Powered by AbleSci AI